IVA Inventiva S.A. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
15:02
Sep 06
Sep 06
Research list of high-risk speculative biotechs
The speaker recommends researching a list of speculative small-cap biotech names, acknowledging high risk, without endorsing a directional trade.
LOW
14:23
Sep 06
Sep 06
IVA watch, educational list
MASH-focused AI-generated idea; author holds no position; educational basket.
MED
13:41
Aug 23
Aug 23
Closed IVA to avoid binary event risk
Author closed his IVA position to avoid another pure binary event after the TENX experience, despite still believing the thesis remains intact.
MED
23:44
Aug 19
Aug 19
Weight gain noted as key drug hurdle
Notes the drug is effective but highlights weight gain as the key hurdle for the upcoming catalyst.
LOW
23:38
Aug 19
Aug 19
The author lists speculative biotech catalysts and best ideas by therapeutic area.
The author lists speculative biotech catalysts and best ideas by therapeutic area as research/watchlist content, not explicit current positions or forward calls.
LOW
23:36
Aug 19
Aug 19
Top biotech picks across various therapeutic areas
Author lists these biotech names as their best ideas across various therapeutic areas with the sector near all-time highs.
MED
13:21
Aug 17
Aug 17
Street accumulating with multiple fund additions
Author holds in their portfolio, observing that the street has been accumulating the stock with additions from multiple funds.
MED
02:38
Aug 16
Aug 16
Partial close IVA to cut binary risk
Author partially closed IVA position (sold half), reducing binary risk exposure following a recent adverse event.
MED
11:27
Aug 15
Aug 15
The author is compiling a research thread of user-recommended non-AI tickers.
The author is compiling a research thread of user-recommended non-AI tickers, listing them as a factual watchlist
LOW
17:25
Aug 10
Aug 10
Highlights past successful biotech valuation calls.
Author lists numerous biotech and pharma tickers as past successful valuation calls, offering no current directional view.
LOW
01:04
Aug 10
Aug 10
IVA long on MASH execution potential
Long IVA as a MASH-focused company with strong execution potential; author holds an unchanged position and views the MASH space as having significant upside contingent on operational delivery.
MED
16:52
Jul 27
Jul 27
Adding to existing long IVA position; author characterizes it as a high-upside bet and plans.
Adding to existing long IVA position; author characterizes it as a high-upside bet and plans to increase exposure imminently.
MED
00:07
Jul 27
Jul 27
The author is highly confident in biotech timing, recommending XBI as a bottom and naming RVMD.
The author is highly confident in biotech timing, recommending XBI as a bottom and naming RVMD, ABVX, TENX, and NKTR as high-conviction longs with specific catalysts and price targets.
18:41
Jul 20
Jul 20
Buy as Phase 3 replication of Phase 2 plus BP acquisition precedent in MASH supports upside.
MED
14:07
Jul 15
Jul 15
Author discloses existing long position in IVA, expressing desire for larger exposure within.
Author discloses existing long position in IVA, expressing desire for larger exposure within the broader XBI bullish thesis of macro tailwinds and record sector M&A.
MED
20:04
Jul 10
Jul 10
Long IVA on Phase 2 data readout expected to translate positively.
Long IVA on Phase 2 data readout expected to translate positively, in a space with established large biopharma M&A interest.
MED
About IVA Analyst Coverage
Buzzberg tracks IVA (Inventiva S.A.) across 4 sources. 4 bullish vs 0 bearish calls from 4 analysts. Sentiment: predominantly bullish (25%). 16 total trade ideas tracked. Past 7 days: 2 watch. Latest voices: sandeman52, aleabitoreddit, seedy19tron.